Ledger.Open graph →
SEC Form D · filed January 4, 2018

vivo-TIL Therapeutics, Inc

Offering
$940K
Sold
$940K
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Laurie O. Beitz · Seattle, WAExecClement A. Erbmann · GREENWOOD VILLAGE, COExecThomas L. Scibetta · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗